RxNorm Semantic Concepts Index - 237
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "237".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 237005 | Levomethadyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237005 | Levomethadyl | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237005 | Levomethadyl | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237005 | Levomethadyl | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237005 | Levomethadyl | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237007 | scoparium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370134 | alpha-tocopherol succinate, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2370136 | 1-o-(2-methoxy-4-hexadecenyl)glycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370138 | 3-(p-methoxyphenyl)propylene-1,2-oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370141 | detosu/triethylene glycol/triethylene glycol polyglycolide copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2370144 | propylene glycol dibutyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370146 | propylene glycol dinitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370147 | selpercatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370147 | selpercatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2370147 | selpercatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2370147 | selpercatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370147 | selpercatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2370148 | Dichrostachys cinerea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370156 | ethanol 0.699 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2370157 | ethanol 69.9 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370157 | ethanol 69.9 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2370157 | ethanol 69.9 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2370158 | benzalkonium chloride 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2370158 | benzalkonium chloride 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2370158 | benzalkonium chloride 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370160 | selpercatinib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2370161 | selpercatinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370161 | selpercatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2370161 | selpercatinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2370162 | selpercatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2370163 | selpercatinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2370164 | selpercatinib 40 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370164 | selpercatinib 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370164 | selpercatinib 40 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2370164 | selpercatinib 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2370165 | Retevmo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2370166 | selpercatinib 40 MG [Retevmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2370167 | selpercatinib Oral Capsule [Retevmo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2370168 | Retevmo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2370169 | Retevmo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2370170 | Retevmo 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370170 | Retevmo 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2370170 | Retevmo 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2370171 | selpercatinib 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2370172 | selpercatinib 80 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370172 | selpercatinib 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370172 | selpercatinib 80 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2370172 | selpercatinib 80 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2370173 | selpercatinib 80 MG [Retevmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2370174 | Retevmo 80 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370174 | Retevmo 80 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2370174 | Retevmo 80 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2370175 | disodium dihydrogen hypophosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237020 | wild yam extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237023 | spike lavender oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2370234 | propofol lipid emulsion 2000 MG in 100 mL Injection (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2370234 | propofol lipid emulsion 2000 MG in 100 mL Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370234 | propofol lipid emulsion 2000 MG in 100 mL Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2370235 | propofol Injection [Propoven] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2370236 | Propoven 2000 MG in 100 mL Injection (EUA) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2370236 | Propoven 2000 MG in 100 mL Injection (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2370236 | Propoven 2000 MG in 100 mL Injection (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2370237 | propofol lipid emulsion 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370238 | propofol lipid emulsion 20 MG/ML Injection [Propoven] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 237025 | halometasone monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237027 | Loteprednol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237027 | Loteprednol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237027 | Loteprednol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237027 | Loteprednol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237027 | Loteprednol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237040 | gastric mucin,pork | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237044 | arbekacin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237057 | lepirudin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237057 | lepirudin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237057 | lepirudin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237057 | lepirudin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237057 | lepirudin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237058 | thonzonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237060 | tormentil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237076 | Prenatal vitamin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237076 | Prenatal vitamin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237082 | Rizatriptan benzoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237082 | Rizatriptan benzoate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237082 | Rizatriptan benzoate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2370867 | Aquaporin-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370867 | Aquaporin-4 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2370867 | Aquaporin-4 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2370868 | acetamidoethoxyethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237087 | bismuth camphocarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370870 | Illicium difengpi bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370871 | Verbena officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370872 | Rubus chingii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370875 | Sigesbeckia orientalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370879 | Narcissus jonquilla flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370881 | polyaminopropyl biguanide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2370886 | 2,4,5-T dimethylammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370887 | camphor 4 % / menthol 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2370887 | camphor 4 % / menthol 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2370887 | camphor 4 % / menthol 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370888 | 2,4-D morpholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370889 | ethyl glycerin acetal levulinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2370900 | menthol 2.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2370901 | benzalkonium / benzocaine / menthol / zinc chloride Oral Cream Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2370902 | benzalkonium / benzocaine / menthol / zinc chloride Oral Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2370903 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2370903 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2370903 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370911 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2370911 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2370911 | camphor 11 % / menthol 16 % / methyl salicylate 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237099 | D-alpha-tocopherol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371 | Chlormerodrin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2371 | Chlormerodrin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2371035 | (3-aminopropyl)diethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371036 | Rosa alba flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371037 | benzyldidecylmethylammonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2371038 | benzyldidecylmethylammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371040 | apomorphine hydrochloride 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371041 | apomorphine Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371042 | apomorphine Sublingual Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371043 | apomorphine HCl 10 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371043 | apomorphine HCl 10 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371043 | apomorphine HCl 10 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371044 | Kynmobi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2371045 | apomorphine hydrochloride 10 MG [Kynmobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371046 | apomorphine Sublingual Film [Kynmobi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371047 | Kynmobi Oral Film Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371048 | Kynmobi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371049 | Kynmobi Sublingual Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371050 | KYNMOBI 10 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371050 | KYNMOBI 10 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371050 | KYNMOBI 10 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371050 | KYNMOBI 10 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371051 | apomorphine hydrochloride 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371052 | apomorphine HCl 15 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371052 | apomorphine HCl 15 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371052 | apomorphine HCl 15 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371053 | apomorphine hydrochloride 15 MG [Kynmobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371054 | KYNMOBI 15 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371054 | KYNMOBI 15 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371054 | KYNMOBI 15 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371054 | KYNMOBI 15 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371055 | apomorphine hydrochloride 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371056 | apomorphine HCl 20 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371056 | apomorphine HCl 20 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371056 | apomorphine HCl 20 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371057 | apomorphine hydrochloride 20 MG [Kynmobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371058 | KYNMOBI 20 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371058 | KYNMOBI 20 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371058 | KYNMOBI 20 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371058 | KYNMOBI 20 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371059 | apomorphine hydrochloride 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371060 | apomorphine HCl 25 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371060 | apomorphine HCl 25 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371060 | apomorphine HCl 25 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371061 | apomorphine hydrochloride 25 MG [Kynmobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371062 | KYNMOBI 25 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371062 | KYNMOBI 25 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371062 | KYNMOBI 25 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371062 | KYNMOBI 25 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371063 | apomorphine hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371064 | apomorphine HCl 30 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371064 | apomorphine HCl 30 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371064 | apomorphine HCl 30 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371065 | apomorphine hydrochloride 30 MG [Kynmobi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371066 | KYNMOBI 30 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371066 | KYNMOBI 30 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371066 | KYNMOBI 30 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371066 | KYNMOBI 30 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371067 | apomorphine HCl 10 MG Sublingual Film (2) / apomorphine HCl 15 MG Sublingual Film (2) / apomorphine HCl 20 MG Sublingual Film (2) / apomorphine HCl 25 MG Sublingual Film (2) / apomorphine HCl 30 MG Sublingual Film (2) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2371067 | apomorphine HCl 10 MG Sublingual Film (2) / apomorphine HCl 15 MG Sublingual Film (2) / apomorphine HCl 20 MG Sublingual Film (2) / apomorphine HCl 25 MG Sublingual Film (2) / apomorphine HCl 30 MG Sublingual Film (2) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371068 | KYNMOBI Titration Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2371068 | KYNMOBI Titration Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371068 | KYNMOBI Titration Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237108 | sodium acetate trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237109 | Disodium citrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237109 | Disodium citrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237110 | Bovine collagen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237110 | Bovine collagen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237112 | Mycophenolate mofetil hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237112 | Mycophenolate mofetil hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237112 | Mycophenolate mofetil hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237115 | grape seed | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237116 | grape seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237119 | magnesium phosphate dibasic trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237123 | dipotassium adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371233 | S-methyl methanethiosulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237124 | sodium phenolsulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2371242 | ethanol 66.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371242 | ethanol 66.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371242 | ethanol 66.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371243 | ethanol 85 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371243 | ethanol 85 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371243 | ethanol 85 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371244 | benzalkonium chloride 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2371245 | benzalkonium chloride 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371245 | benzalkonium chloride 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371245 | benzalkonium chloride 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371246 | isopropyl alcohol 74 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371246 | isopropyl alcohol 74 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371246 | isopropyl alcohol 74 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371247 | isopropyl alcohol 60 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371247 | isopropyl alcohol 60 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371247 | isopropyl alcohol 60 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237125 | Sevelamer hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237125 | Sevelamer hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237125 | Sevelamer hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371254 | acetaminophen 325 MG / pyrilamine maleate 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371254 | acetaminophen 325 MG / pyrilamine maleate 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371254 | acetaminophen 325 MG / pyrilamine maleate 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371255 | acetaminophen 260 MG / caffeine 32 MG / guaiFENesin 100 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237126 | Acanthophis antarcticus antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237126 | Acanthophis antarcticus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237126 | Acanthophis antarcticus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2371263 | phenylephrine hydrochloride 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2371267 | acetaminophen 500 MG / caffeine 50 MG / magnesium salicylate 500 MG / phenyltoloxamine citrate 20 MG [Durabac Forte] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 237127 | Oxyuranus scutellatus antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237127 | Oxyuranus scutellatus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237127 | Oxyuranus scutellatus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2371270 | acetaminophen 500 MG / codeine phosphate 50 MG / magnesium salicylate 500 MG / phenyltoloxamine citrate 20 MG [Combiflex ES] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371273 | acetaminophen 500 MG / phenyltoloxamine citrate 30 MG [Dolorex brand of acetaminophen-phenyltoloxamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371275 | phenylpropanolamine hydrochloride 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2371278 | phenylpropanolamine hydrochloride 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 237128 | Notechis scutatus antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237128 | Notechis scutatus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237128 | Notechis scutatus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237128 | Notechis scutatus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237128 | Notechis scutatus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237131 | Enhydrina schistosa antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237131 | Enhydrina schistosa antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237131 | Enhydrina schistosa antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237131 | Enhydrina schistosa antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237131 | Enhydrina schistosa antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237134 | Chironex fleckeri antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237134 | Chironex fleckeri antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237134 | Chironex fleckeri antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237135 | Ixodes holocyclus antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237135 | Ixodes holocyclus antivenom | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237135 | Ixodes holocyclus antivenom | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237141 | tibezonium iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237144 | Tetrahydrofurfuryl salicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237144 | Tetrahydrofurfuryl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237144 | Tetrahydrofurfuryl salicylate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237144 | Tetrahydrofurfuryl salicylate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237148 | bismuth-formic-iodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237152 | Recombinant human glucagon | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237152 | Recombinant human glucagon | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237159 | Levosalbutamol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237160 | Levosalbutamol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237160 | Levosalbutamol hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237160 | Levosalbutamol hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237160 | Levosalbutamol hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237162 | Dexketoprofen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237162 | Dexketoprofen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237162 | Dexketoprofen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237162 | Dexketoprofen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237162 | Dexketoprofen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237163 | acetylcysteine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237165 | digoxin 50 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237165 | digoxin 50 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237165 | digoxin 50 MCG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237165 | digoxin 50 MCG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237166 | digoxin 100 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237166 | digoxin 100 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237166 | digoxin 100 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237166 | digoxin 100 MCG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237166 | digoxin 100 MCG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2371688 | Viola odorata leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371688 | Viola odorata leaf oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371689 | triethoxy(3-isocyanatopropyl)silane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237169 | digoxin 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371699 | (6E)-(+)-nerolidol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371699 | (6E)-(+)-nerolidol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237170 | caffeine 150 MG / glucose 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371700 | .alpha.-pinene, (+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2371701 | acetyl tetrapeptide-11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371702 | .beta.-ionone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2371703 | .delta.-decalactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2371704 | .delta.-dodecalactone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2371705 | hydrolyzed Lupinus albus seed protein (enzymatic; 3500 mw) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371710 | glycopyrrolate 1 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371710 | glycopyrrolate 1 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371710 | glycopyrrolate 1 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371711 | Glyrx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2371712 | glycopyrrolate 0.2 MG/ML [Glyrx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371713 | glycopyrronium Prefilled Syringe [Glyrx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371714 | Glyrx Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371715 | Glyrx-PF 1 MG in 5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371715 | Glyrx-PF 1 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371715 | Glyrx-PF 1 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371715 | Glyrx-PF 1 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371716 | glycopyrrolate 0.2 MG/ML Prefilled Syringe [Glyrx] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371716 | glycopyrrolate 0.2 MG/ML Prefilled Syringe [Glyrx] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371717 | glycopyrronium Injection [Glyrx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371718 | Glyrx-PF 0.2 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371718 | Glyrx-PF 0.2 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371718 | Glyrx-PF 0.2 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371718 | Glyrx-PF 0.2 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371719 | glycopyrrolate 0.2 MG/ML Injection [Glyrx] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371719 | glycopyrrolate 0.2 MG/ML Injection [Glyrx] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237172 | caffeine 200 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371720 | petrolatum 0.462 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2371721 | camphor 1.7 % / petrolatum, white 46.2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371721 | camphor 1.7 % / petrolatum, white 46.2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371721 | camphor 1.7 % / petrolatum, white 46.2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371722 | dapagliflozin / metformin / saxagliptin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371722 | dapagliflozin / metformin / saxagliptin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371722 | dapagliflozin / metformin / saxagliptin Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2371722 | dapagliflozin / metformin / saxagliptin Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371723 | dapagliflozin / metformin / saxagliptin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371723 | dapagliflozin / metformin / saxagliptin Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371724 | dapagliflozin / metformin / saxagliptin Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371724 | dapagliflozin / metformin / saxagliptin Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371725 | dapagliflozin 10 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371725 | dapagliflozin 10 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371725 | dapagliflozin 10 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371725 | dapagliflozin 10 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371725 | dapagliflozin 10 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371726 | Qternmet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2371727 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG [Qternmet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371727 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371728 | dapagliflozin / metformin / saxagliptin Extended Release Oral Tablet [Qternmet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371728 | dapagliflozin / metformin / saxagliptin Extended Release Oral Tablet [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371729 | Qternmet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 237173 | caffeine 250 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237173 | caffeine 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371730 | Qternmet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371731 | Qternmet XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371731 | Qternmet XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371731 | Qternmet XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371731 | Qternmet XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371731 | Qternmet XR 10 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371732 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371732 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371733 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet [Qternmet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371733 | dapagliflozin 10 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371734 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371734 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371734 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371734 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371734 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371735 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG [Qternmet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371735 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371736 | Qternmet XR 2.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371736 | Qternmet XR 2.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371736 | Qternmet XR 2.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371736 | Qternmet XR 2.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2371736 | Qternmet XR 2.5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371737 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371737 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371738 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet [Qternmet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371738 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237174 | caffeine 12 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371740 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371740 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371740 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371740 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371740 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 2.5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371741 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG [Qternmet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371741 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371742 | Qternmet XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371742 | Qternmet XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371742 | Qternmet XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371742 | Qternmet XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371742 | Qternmet XR 5 MG / 2.5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371743 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371743 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371744 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet [Qternmet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371744 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371745 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371745 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371745 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371745 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371745 | dapagliflozin 5 MG / metFORMIN HCl 1000 MG / sAXagliptin 5 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371746 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG [Qternmet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371746 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371747 | Qternmet XR 5 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371747 | Qternmet XR 5 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371747 | Qternmet XR 5 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371747 | Qternmet XR 5 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371747 | Qternmet XR 5 MG / 5 MG / 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371748 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371748 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371749 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet [Qternmet] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371749 | dapagliflozin 5 MG / metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet [Qternmet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237175 | ephedrine / phenobarbital / potassium iodide / theophylline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237175 | ephedrine / phenobarbital / potassium iodide / theophylline Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371750 | ascorbic acid / calcium carbonate / cholecalciferol / copper sulfate / ferrous fumarate / folic acid / magnesium oxide / niacinamide / potassium iodide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin E / zinc sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371751 | ascorbic acid / calcium carbonate / cholecalciferol / copper sulfate / ferrous fumarate / folic acid / magnesium oxide / niacinamide / potassium iodide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin E / zinc sulfate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371752 | ascorbic acid / calcium carbonate / cholecalciferol / copper sulfate / ferrous fumarate / folic acid / magnesium oxide / niacinamide / potassium iodide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin E / zinc sulfate Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371753 | ascorbic acid / calcium carbonate / cholecalciferol / copper sulfate / ferrous fumarate / folic acid / magnesium oxide / niacinamide / potassium iodide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin E / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2371755 | ascorbic acid 100 MG / calcium carbonate 200 MG / cholecalciferol 0.01 MG / copper sulfate 2 MG / dl-alpha tocopheryl acetate 30 UNT / ferrous fumarate 65 MG / folic acid 1 MG / magnesium oxide 10 MG / niacinamide 20 MG / potassium iodide 0.15 MG / pyridoxine hydrochloride 5 MG / retinol acetate 4000 UNT / riboflavin 3.4 MG / thiamine mononitrate 3 MG / vitamin B12 0.012 MG / zinc sulfate 15 MG [Lactocal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371756 | ascorbic acid / calcium carbonate / cholecalciferol / copper sulfate / ferrous fumarate / folic acid / magnesium oxide / niacinamide / potassium iodide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin E / zinc sulfate Oral Tablet [Lactocal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371759 | elagolix 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371760 | Elagolix- and estradiol- and norethisterone-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371760 | Elagolix- and estradiol- and norethisterone-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2371760 | Elagolix- and estradiol- and norethisterone-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371760 | Elagolix- and estradiol- and norethisterone-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371761 | elagolix / estradiol / norethindrone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371762 | elagolix / estradiol / norethindrone Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371763 | Elagolix- and estradiol- and norethisterone-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2371763 | Elagolix- and estradiol- and norethisterone-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2371763 | Elagolix- and estradiol- and norethisterone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371763 | Elagolix- and estradiol- and norethisterone-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371764 | elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371764 | elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371764 | elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2371764 | elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371764 | elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371765 | elagolix Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371766 | elagolix 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371766 | elagolix 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371766 | elagolix 300 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2371766 | elagolix 300 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2371767 | (elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG (28) Oral Capsule) / (elagolix 300 MG (28) Oral Capsule) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371767 | (elagolix 300 MG / estradiol 1 MG / norethindrone 0.5 MG (28) Oral Capsule) / (elagolix 300 MG (28) Oral Capsule) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2371768 | Oriahnn 28 Day Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2371768 | Oriahnn 28 Day Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371768 | Oriahnn 28 Day Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371769 | Fensolvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 237177 | ephedrine / hydroxyzine / theophylline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237177 | ephedrine / hydroxyzine / theophylline Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371770 | leuprolide acetate 120 MG/ML [Fensolvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371771 | leuprolide Prefilled Syringe [Fensolvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371772 | Fensolvi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2371773 | Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371773 | Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371773 | Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371773 | Fensolvi 45 MG in 0.375 ML (6 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371774 | leuprolide acetate 120 MG/ML Prefilled Syringe [Fensolvi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371774 | leuprolide acetate 120 MG/ML Prefilled Syringe [Fensolvi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371776 | vitamin A 0.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371777 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371778 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371779 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 237178 | theophylline 100 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237178 | theophylline 100 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2371780 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371781 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2371783 | ascorbic acid 60 MG / cholecalciferol 0.01 MG / folic acid 0.3 MG / niacin 13.5 MG / riboflavin 1.2 MG / sodium fluoride 2.2 MG / thiamine 1.05 MG / vitamin A 0.75 MG / vitamin B12 0.0045 MG / vitamin B6 1.05 MG / vitamin E 15 UNT [MVC-Fluoride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371784 | ascorbic acid / cholecalciferol / folic acid / niacin / riboflavin / sodium fluoride / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Chewable Tablet [MVC-Fluoride] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371787 | vitamin E 2.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371788 | ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin A / vitamin B6 / vitamin E Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2371789 | ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin A / vitamin B6 / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2371790 | ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin A / vitamin B6 / vitamin E Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2371791 | ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin A / vitamin B6 / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2371793 | ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / ferrous sulfate 50 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML [Poly-Vi-Sol with Iron] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371794 | ascorbic acid / cholecalciferol / ferrous sulfate / niacin / riboflavin / thiamine / vitamin A / vitamin B6 / vitamin E Oral Solution [Poly-Vi-Sol with Iron] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2371796 | Glyrx-PF 0.4 MG in 2 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371796 | Glyrx-PF 0.4 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371796 | Glyrx-PF 0.4 MG in 2 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2371796 | Glyrx-PF 0.4 MG in 2 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2371797 | ascorbic acid / cholecalciferol / niacin / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371798 | ascorbic acid / cholecalciferol / niacin / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2371799 | ascorbic acid / cholecalciferol / niacin / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2371800 | ascorbic acid / cholecalciferol / niacin / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2371802 | ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML [Poly-Vi-Sol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2371803 | ascorbic acid / cholecalciferol / niacin / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin B6 / vitamin E Oral Solution [Poly-Vi-Sol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2371805 | vitamin A 0.24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 237182 | ephedrine / guaifenesin / theophylline Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237182 | ephedrine / guaifenesin / theophylline Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237183 | dyphylline / ephedrine / guaifenesin / phenobarbital Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237183 | dyphylline / ephedrine / guaifenesin / phenobarbital Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237187 | EPINEPHrine 10 MG/ML Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237187 | EPINEPHrine 10 MG/ML Inhalation Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371908 | benzalkonium chloride 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371908 | benzalkonium chloride 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371908 | benzalkonium chloride 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371909 | benzalkonium chloride 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371909 | benzalkonium chloride 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371909 | benzalkonium chloride 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237192 | reserpine 0.125 MG / chlorothiazide 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237192 | reserpine 0.125 MG / chlorothiazide 250 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237192 | reserpine 0.125 MG / chlorothiazide 250 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237192 | reserpine 0.125 MG / chlorothiazide 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371954 | copper(II) nitrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371954 | copper(II) nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2371956 | ascorbic acid / cholecalciferol / sodium fluoride / vitamin A Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2371957 | ascorbic acid / cholecalciferol / sodium fluoride / vitamin A Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2371958 | ascorbic acid / cholecalciferol / sodium fluoride / vitamin A Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2371960 | vitamin E 6.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371964 | cholecalciferol 135 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371965 | vitamin A 0.375 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371967 | cholecalciferol 270 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2371978 | benzalkonium chloride 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2371979 | benzalkonium chloride 0.6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2371979 | benzalkonium chloride 0.6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2371979 | benzalkonium chloride 0.6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2371986 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Alphen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371986 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Alphen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371988 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Cyndal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371988 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Cyndal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371990 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Efasin Expectorant SF] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371990 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Efasin Expectorant SF] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371992 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Endal Expectorant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371992 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Endal Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371994 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Enditussin Expectorant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371994 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Enditussin Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2371996 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Endotuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2371996 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Endotuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2372 | Clomethiazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372 | Clomethiazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2372 | Clomethiazole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2372 | Clomethiazole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372 | Clomethiazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2372 | Clomethiazole | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372 | Clomethiazole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237205 | nitroglycerin 50 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237205 | nitroglycerin 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237205 | nitroglycerin 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237205 | nitroglycerin 50 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237205 | nitroglycerin 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2372087 | Citrus bergamia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 237210 | papaverine HCl 30 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237210 | papaverine HCl 30 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237210 | papaverine HCl 30 MG/ML Injectable Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237210 | papaverine HCl 30 MG/ML Injectable Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237212 | alprostadil 500 MCG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237212 | alprostadil 500 MCG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237212 | alprostadil 500 MCG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237212 | alprostadil 500 MCG in 1 ML Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237212 | alprostadil 500 MCG in 1 ML Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2372199 | daratumumab / hyaluronidase | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2372219 | myristyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372221 | fluoroestradiol F-18 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2372221 | fluoroestradiol F-18 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2372221 | fluoroestradiol F-18 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2372221 | fluoroestradiol F-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2372221 | fluoroestradiol F-18 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2372226 | eugenol 0.07 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2372227 | camphor / eugenol / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2372228 | camphor / eugenol / menthol Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2372229 | camphor / eugenol / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2372230 | camphor 10 % / eugenol 7 % / menthol 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372230 | camphor 10 % / eugenol 7 % / menthol 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372230 | camphor 10 % / eugenol 7 % / menthol 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372235 | aspirin 500 MG / phenyltoloxamine citrate 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372235 | aspirin 500 MG / phenyltoloxamine citrate 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372235 | aspirin 500 MG / phenyltoloxamine citrate 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372236 | aspirin 500 MG / phenyltoloxamine citrate 15 MG [Momentum tradename] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2372237 | Momentum tradename (500 MG / 15 MG) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372237 | Momentum tradename (500 MG / 15 MG) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2372237 | Momentum tradename (500 MG / 15 MG) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372242 | APAP 162 MG / ASA 162 MG / phenylpropanolamine hydrochloride 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372242 | APAP 162 MG / ASA 162 MG / phenylpropanolamine hydrochloride 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372244 | caffeine 100 MG / phenylpropanolamine hydrochloride 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372245 | phenylpropanolamine bitartrate 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2372246 | ASA 1.63 MG/ML / phenylpropanolamine bitartrate 0.1 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372246 | ASA 1.63 MG/ML / phenylpropanolamine bitartrate 0.1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372247 | acetaminophen 500 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372247 | acetaminophen 500 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372247 | acetaminophen 500 MG / phenylpropanolamine HCl 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372436 | dry biocellulose (MW 2000000) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372437 | 2-nitropropane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372438 | camphor 5 % / menthol 8 % / methyl salicylate 10 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372438 | camphor 5 % / menthol 8 % / methyl salicylate 10 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372438 | camphor 5 % / menthol 8 % / methyl salicylate 10 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372450 | ethanol 0.702 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2372451 | ethanol 70.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372451 | ethanol 70.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372451 | ethanol 70.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372452 | ethanol 0.646 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2372453 | ethanol 64.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2372453 | ethanol 64.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372453 | ethanol 64.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372454 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372454 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372454 | benzalkonium chloride 0.1 % / ethanol 70 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237248 | guaiFENesin 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237248 | guaiFENesin 300 MG Oral Capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237248 | guaiFENesin 300 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237248 | guaiFENesin 300 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 237248 | guaiFENesin 300 MG Oral Capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2372689 | flortaucipir F-18 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2372689 | flortaucipir F-18 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2372689 | flortaucipir F-18 | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2372689 | flortaucipir F-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2372689 | flortaucipir F-18 | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2372690 | Senergy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2372691 | selamectin 120 MG/ML [Senergy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2372692 | selamectin Topical Solution [Senergy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2372693 | Senergy Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2372694 | SENERGY 120 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2372694 | SENERGY 120 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372694 | SENERGY 120 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372695 | selamectin 60 MG/ML [Senergy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2372696 | SENERGY 60 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2372696 | SENERGY 60 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2372696 | SENERGY 60 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2372697 | clonitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2372698 | limonene oxide, trans-(+)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2372911 | Licart 1.3 % Once-Daily Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2372911 | Licart 1.3 % Once-Daily Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2372911 | Licart 1.3 % Once-Daily Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2372911 | Licart 1.3 % Once-Daily Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2372915 | Lactarius rubidus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2372916 | 2-propenoic acid, 2-cyano-3,3-diphenyl-2,2-bis(((2-cyano-1-oxo-3,3-diphenyl-2-propenyl)oxy)methyl)-1,3-propanediyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372917 | capryl oligoglucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2372918 | dihydro pentamethylindanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2372919 | dimethicone/PEG-10/15 crosspolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2372920 | 2,3 di-o-methyl-d-glucose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2373 | Chlormethazanone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2373021 | Eberconazole nitrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2373021 | Eberconazole nitrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2373025 | ergocalciferol 0.025 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373029 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Chemdal Expectorant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373029 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Chemdal Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373032 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Codegest] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373032 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Codegest] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373034 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Naldecon CX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373034 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Naldecon CX] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373036 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Quindal Solution] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373036 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Quindal Solution] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373038 | ergocalciferol 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373040 | ergocalciferol 0.625 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373044 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Statuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373044 | codeine phosphate 2 MG/ML / guaifenesin 40 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Statuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373046 | ergocalciferol 0.207 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373049 | cholecalciferol 0.0025 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373051 | cholecalciferol 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373054 | cholecalciferol 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373056 | cholecalciferol 0.2 MG/ML [Bio-D-Mulsion] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373058 | cholecalciferol 0.357 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373060 | cholecalciferol 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373062 | cholecalciferol 0.833 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373065 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Codamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373065 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Codamine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373066 | cholecalciferol 1.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373069 | cholecalciferol 0.002 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373071 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Hycomine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373071 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Hycomine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373075 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Hycophen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373075 | hydrocodone bitartrate 0.5 MG/ML / phenylpropanolamine hydrochloride 2.5 MG/ML [Hycophen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373079 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Codamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373079 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Codamine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373081 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hycomine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373081 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hycomine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373083 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hycophen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373083 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hycophen] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373085 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hypamine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373085 | hydrocodone bitartrate 1 MG/ML / phenylpropanolamine hydrochloride 5 MG/ML [Hypamine] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2373093 | caramiphen edisylate 1.34 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373095 | caramiphen edisylate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2373097 | caramiphen edisylate 40 MG / phenylpropanolamine hydrochloride 75 MG [Ordrine AT] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2373234 | ethanol 79 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373234 | ethanol 79 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2373234 | ethanol 79 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237325 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylpropanolamine HCl 40 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237325 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylpropanolamine HCl 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237325 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylpropanolamine HCl 40 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237325 | acetaminophen 325 MG / chlorpheniramine maleate 4 MG / phenylpropanolamine HCl 40 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373431 | lidocaine 2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2373431 | lidocaine 2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373431 | lidocaine 2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373436 | didodecyldimethylammonium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373437 | Ethyl methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373437 | Ethyl methacrylate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2373437 | Ethyl methacrylate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2373437 | Ethyl methacrylate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2373437 | Ethyl methacrylate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2373439 | octadecanoic acid, (octadecylimino)di-2,1-ethanediyl ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373440 | triisopropylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373441 | dextromethorphan HBr 10 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373441 | dextromethorphan HBr 10 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373441 | dextromethorphan HBr 10 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373442 | activated charcoal 520 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373443 | activated charcoal 520 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373443 | activated charcoal 520 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373444 | ethanol 77 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373444 | ethanol 77 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2373444 | ethanol 77 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373447 | ethanol 83 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373447 | ethanol 83 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2373447 | ethanol 83 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373451 | celecoxib 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373452 | celecoxib Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2373453 | celecoxib Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2373454 | celecoxib 120 MG in 4.8 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373454 | celecoxib 120 MG in 4.8 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373455 | Elyxyb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2373456 | celecoxib 25 MG/ML [Elyxyb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2373457 | celecoxib Oral Solution [Elyxyb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2373458 | Elyxyb Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2373459 | Elyxyb Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2373460 | Elyxyb 120 MG in 4.8 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2373460 | Elyxyb 120 MG in 4.8 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373460 | Elyxyb 120 MG in 4.8 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237357 | NaHCO3 0.6 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237357 | NaHCO3 0.6 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373647 | pimenta oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373647 | pimenta oil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373647 | pimenta oil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2373647 | pimenta oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373648 | lavender jobfish whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373649 | geranial propylene glycol acetal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373651 | beta-carotene, (9Z)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2373652 | Stem bromelain | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373652 | Stem bromelain | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373652 | Stem bromelain | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237367 | potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237367 | potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237367 | potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237367 | potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237367 | potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237371 | sodium acetate 2 MEQ/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237371 | sodium acetate 2 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237378 | sodium lactate 50 MEQ in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237378 | sodium lactate 50 MEQ in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237378 | sodium lactate 50 MEQ in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237381 | potassium acetate 2 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237381 | potassium acetate 2 MEQ/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237381 | potassium acetate 2 MEQ/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237381 | potassium acetate 2 MEQ/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237382 | potassium acetate 200 MEQ in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237382 | potassium acetate 200 MEQ in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237382 | potassium acetate 200 MEQ in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237382 | potassium acetate 200 MEQ in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237382 | potassium acetate 200 MEQ in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237389 | K+ Chloride 2.5 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237389 | K+ Chloride 2.5 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237389 | K+ Chloride 2.5 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237393 | potassium gluconate 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237393 | potassium gluconate 2 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237393 | potassium gluconate 2 MEQ Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237393 | potassium gluconate 2 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373938 | bedaquiline 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373939 | bedaquiline 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373939 | bedaquiline 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373939 | bedaquiline 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373939 | bedaquiline 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373939 | bedaquiline 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2373940 | bedaquiline 20 MG [Sirturo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2373941 | Sirturo 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2373941 | Sirturo 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373941 | Sirturo 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373941 | Sirturo 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373942 | dipropylene glycol monocaprate monocaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373947 | 3,7-dimethyl-3-octanol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373947 | 3,7-dimethyl-3-octanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373948 | 2,2'-oxydipropanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373950 | inebilizumab-cdon | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2373951 | inebilizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373951 | inebilizumab | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373951 | inebilizumab | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2373951 | inebilizumab | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373951 | inebilizumab | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2373952 | inebilizumab-cdon 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2373953 | inebilizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2373953 | inebilizumab Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2373953 | inebilizumab Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2373954 | inebilizumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2373955 | inebilizumab-cdon 100 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2373955 | inebilizumab-cdon 100 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373955 | inebilizumab-cdon 100 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373956 | Uplizna | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2373957 | inebilizumab-cdon 10 MG/ML [Uplizna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2373958 | inebilizumab Injection [Uplizna] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2373959 | Uplizna Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 237396 | Pot 3 MEQ/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237396 | Pot 3 MEQ/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237396 | Pot 3 MEQ/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373960 | UPLIZNA 100 MG in10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2373960 | UPLIZNA 100 MG in10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373960 | UPLIZNA 100 MG in10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373960 | UPLIZNA 100 MG in10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373961 | inebilizumab-cdon 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2373962 | inebilizumab-cdon 10 MG/ML Injection [Uplizna] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2373962 | inebilizumab-cdon 10 MG/ML Injection [Uplizna] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2373963 | 2-butylaminoethanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2373964 | laureth-9 phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2373965 | sandalore | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2373966 | inebilizumab-cdon 100 MG in 10 ML (3) Injection Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2373966 | inebilizumab-cdon 100 MG in 10 ML (3) Injection Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373966 | inebilizumab-cdon 100 MG in 10 ML (3) Injection Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373966 | inebilizumab-cdon 100 MG in 10 ML (3) Injection Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2373967 | UPLIZNA 3 Vial Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2373967 | UPLIZNA 3 Vial Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2373967 | UPLIZNA 3 Vial Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374 | chloroacetic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237402 | calcium carbonate 600 UNT / vitamin D2 200 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237402 | calcium carbonate 600 UNT / vitamin D2 200 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237402 | calcium carbonate 600 UNT / vitamin D2 200 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237402 | calcium carbonate 600 UNT / vitamin D2 200 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237406 | calcium carbonate 500 MG / vitamin D2 375 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237406 | calcium carbonate 500 MG / vitamin D2 375 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237406 | calcium carbonate 500 MG / vitamin D2 375 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237406 | calcium carbonate 500 MG / vitamin D2 375 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23742 | Dyazide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 237420 | calcium 600 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237420 | calcium 600 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237420 | calcium 600 MG Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237421 | calcium carbonate 625 MG (Ca 250 MG) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237421 | calcium carbonate 625 MG (Ca 250 MG) Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237424 | calcium gluceptate 220 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237426 | calcium phosphate 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374330 | artesunate 110 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374331 | artesunate Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2374332 | artesunate 110 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374332 | artesunate 110 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374332 | artesunate 110 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2374332 | artesunate 110 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374337 | Darunavir propylene glycolate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2374337 | Darunavir propylene glycolate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2374339 | benzylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374340 | Chamaecyparis lawsoniana wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374347 | sodium myreth sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374348 | viridiflorol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2374349 | 1-bromo-3-chloro-5,5-dimethyl-2,4-imidazolidinedione | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374352 | poloxamine 1304 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374357 | povidone-iodine 0.005 MG/MG [Betadine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374358 | Betadine 0.5 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374358 | Betadine 0.5 % Powder Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374358 | Betadine 0.5 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374358 | Betadine 0.5 % Powder Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374360 | acetaminophen 500 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374360 | acetaminophen 500 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374360 | acetaminophen 500 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374361 | Tylenol DISSOLVE PACKS 500 MG Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374361 | Tylenol DISSOLVE PACKS 500 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374361 | Tylenol DISSOLVE PACKS 500 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374361 | Tylenol DISSOLVE PACKS 500 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374362 | povidone-iodine 5 MG/ML [Betadine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374363 | Betadine 0.5 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374363 | Betadine 0.5 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374363 | Betadine 0.5 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374363 | Betadine 0.5 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374364 | fosnetupitant 11.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374365 | palonosetron 0.0125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374366 | fosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374366 | fosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374366 | fosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374366 | fosnetupitant 235 MG / palonosetron 0.25 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374367 | fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML [Akynzeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374368 | Akynzeo 235 MG / 0.25 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374368 | Akynzeo 235 MG / 0.25 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374368 | Akynzeo 235 MG / 0.25 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374369 | fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374370 | fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection [Akynzeo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2374372 | ethanol 0.655 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2374373 | ethanol 65.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374373 | ethanol 65.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374373 | ethanol 65.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23744 | dyclonine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 23744 | dyclonine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 23744 | dyclonine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 23744 | dyclonine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 23744 | dyclonine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374547 | isopropyl alcohol 0.03 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2374548 | ethanol 70 % / isopropyl alcohol 3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374548 | ethanol 70 % / isopropyl alcohol 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374548 | ethanol 70 % / isopropyl alcohol 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374549 | 1-(3,4-dimethoxyphenyl)propane-1,2-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374550 | PEG-70 lanolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374551 | Jammu lemongrass oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374552 | Aloe succotrina whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374553 | dimethicone PEG-7 panthenyl phosphate (12 panthenol) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374554 | acetaminophen 650 MG / diphenhydrAMINE HCl 25 MG 20 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2374555 | eravacycline 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374556 | eravacycline 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374556 | eravacycline 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374556 | eravacycline 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374557 | eravacycline 100 MG [Xerava] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374558 | XERAVA 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374558 | XERAVA 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374558 | XERAVA 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374559 | dolutegravir 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374560 | dolutegravir Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2374561 | dolutegravir Tablet for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2374562 | dolutegravir 5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374562 | dolutegravir 5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374562 | dolutegravir 5 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374563 | dolutegravir 5 MG [Tivicay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374564 | dolutegravir Tablet for Oral Suspension [Tivicay] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374565 | Tivicay Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374566 | Tivicay PD 5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374567 | ethanol 0.756 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2374568 | ethanol 75.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374568 | ethanol 75.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374568 | ethanol 75.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374585 | estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Syntest] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2374585 | estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Syntest] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2374724 | ethanol 0.615 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2374725 | ethanol 61.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374725 | ethanol 61.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374725 | ethanol 61.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374726 | ethanol 0.724 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2374727 | ethanol 72.4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374727 | ethanol 72.4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374727 | ethanol 72.4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374729 | lurbinectedin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2374729 | lurbinectedin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2374729 | lurbinectedin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374729 | lurbinectedin | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2374729 | lurbinectedin | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374730 | lurbinectedin 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2374731 | lurbinectedin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2374731 | lurbinectedin Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2374731 | lurbinectedin Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374732 | lurbinectedin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2374733 | lurbinectedin 4 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374733 | lurbinectedin 4 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2374733 | lurbinectedin 4 MG Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2374733 | lurbinectedin 4 MG Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2374734 | Zepzelca | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2374735 | lurbinectedin 4 MG [Zepzelca] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2374736 | lurbinectedin Injection [Zepzelca] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374737 | Zepzelca Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2374738 | ZEPZELCA 4 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2374738 | ZEPZELCA 4 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2374738 | ZEPZELCA 4 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2374739 | fructose, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2374740 | camphor 4.7 % / eucalyptus oil 1 % / menthol 1.25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2374740 | camphor 4.7 % / eucalyptus oil 1 % / menthol 1.25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2374740 | camphor 4.7 % / eucalyptus oil 1 % / menthol 1.25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374741 | Zoarces americanus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374741 | Zoarces americanus preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237486 | ferrous sulfate 39 MG (iron 7.8 MG) / vitamin C 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237486 | ferrous sulfate 39 MG (iron 7.8 MG) / vitamin C 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237486 | ferrous sulfate 39 MG (iron 7.8 MG) / vitamin C 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237486 | ferrous sulfate 39 MG (iron 7.8 MG) / vitamin C 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2374913 | Freesia alba whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374914 | 3,3'-dihydroxydipropyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374915 | dicocoyl pentaerythrityl distearyl citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374916 | pyridoxal 5-phosphate glutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2374917 | alpha-methylbenzyl acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2374918 | 4-tert-butylcyclohexanyl acetate, trans- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2374919 | Bifidobacterium lactis Bi-07 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2375030 | Speranskia tuberculata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375032 | zinc pyrithione 1 % / panthenol 0.5 % / niacinamide 0.3 % / biotin 0.06 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375032 | zinc pyrithione 1 % / panthenol 0.5 % / niacinamide 0.3 % / biotin 0.06 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375032 | zinc pyrithione 1 % / panthenol 0.5 % / niacinamide 0.3 % / biotin 0.06 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375038 | ethanol 0.902 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375039 | ethanol 90.2 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375039 | ethanol 90.2 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375039 | ethanol 90.2 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237504 | iron soy protein complex 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237504 | iron soy protein complex 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375040 | ethanol 0.9 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375041 | ethanol 90 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375041 | ethanol 90 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375041 | ethanol 90 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375043 | benzalkonium chloride 0.14 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375043 | benzalkonium chloride 0.14 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375043 | benzalkonium chloride 0.14 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375044 | polyaminopropyl biguanide 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375045 | benzalkonium / polyaminopropyl biguanide Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2375046 | benzalkonium / polyaminopropyl biguanide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2375047 | benzalkonium / polyaminopropyl biguanide Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2375048 | benzalkonium / polyaminopropyl biguanide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2375049 | benzalkonium chloride 0.12 % / polyaminopropyl biguanide 0.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375049 | benzalkonium chloride 0.12 % / polyaminopropyl biguanide 0.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375049 | benzalkonium chloride 0.12 % / polyaminopropyl biguanide 0.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237505 | ferrous sulfate 150 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237505 | ferrous sulfate 150 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237505 | ferrous sulfate 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237505 | ferrous sulfate 150 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237506 | ferrous sulfate 325 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237506 | ferrous sulfate 325 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237506 | ferrous sulfate 325 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237506 | ferrous sulfate 325 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237508 | zinc 10 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237508 | zinc 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237508 | zinc 10 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237509 | zinc gluconate 105 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237509 | zinc gluconate 105 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237510 | zinc gluconate 77 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237510 | zinc gluconate 77 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237510 | zinc gluconate 77 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237511 | zinc sulfate 10 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237511 | zinc sulfate 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237511 | zinc sulfate 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237511 | zinc sulfate 10 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237511 | zinc sulfate 10 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237512 | zinc sulfate 25 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237512 | zinc sulfate 25 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237512 | zinc sulfate 25 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237512 | zinc sulfate 25 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237512 | zinc sulfate 25 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375130 | daratumumab-fihj | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2375131 | daratumumab-fihj 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2375132 | hyaluronidase-fihj | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2375133 | hyaluronidase-fihj 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2375134 | daratumumab / hyaluronidase Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2375135 | daratumumab / hyaluronidase Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2375136 | daratumumab-fihj 1800 MG / hyaluronidase-fihj 30,000 UNT in 15 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375136 | daratumumab-fihj 1800 MG / hyaluronidase-fihj 30,000 UNT in 15 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375136 | daratumumab-fihj 1800 MG / hyaluronidase-fihj 30,000 UNT in 15 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375137 | Darzalex Faspro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2375138 | daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML [Darzalex Faspro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2375139 | daratumumab / hyaluronidase Injection [Darzalex Faspro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375140 | Darzalex Faspro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2375141 | DARZALEX Faspro 1800 MG / 30,000 UNT in 15 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375141 | DARZALEX Faspro 1800 MG / 30,000 UNT in 15 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375141 | DARZALEX Faspro 1800 MG / 30,000 UNT in 15 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375141 | DARZALEX Faspro 1800 MG / 30,000 UNT in 15 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375142 | daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375143 | daratumumab-fihj 120 MG/ML / hyaluronidase-fihj 2000 UNT/ML Injection [Darzalex Faspro] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375144 | sodium polystyrene sulfonate 15000 MG [Kionex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2375145 | sodium polystyrene sulfonate Powder for Oral Suspension [Kionex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375146 | Kionex Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2375147 | Kionex 15000 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375147 | Kionex 15000 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375147 | Kionex 15000 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 237521 | manganese 1 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237521 | manganese 1 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237521 | manganese 1 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237522 | manganese sulfate 1 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237522 | manganese sulfate 1 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237522 | manganese sulfate 1 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237527 | insulin, human lente 100 UNT/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237527 | insulin, human lente 100 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237528 | insulin, human ultralente 100 UNT/ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237528 | insulin, human ultralente 100 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375302 | benzalkonium chloride 2.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375303 | benzalkonium chloride 0.23 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375303 | benzalkonium chloride 0.23 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375303 | benzalkonium chloride 0.23 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375304 | isopropyl alcohol 0.8 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375305 | isopropyl alcohol 80 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375305 | isopropyl alcohol 80 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375305 | isopropyl alcohol 80 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375307 | dioleylamidoethyl(diethoxylated-hydroxyethyl)monium methosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375318 | solifenacin succinate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2375319 | solifenacin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2375320 | solifenacin Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2375321 | solifenacin succinate 5 MG in 5 mL Oral Suspension | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2375321 | solifenacin succinate 5 MG in 5 mL Oral Suspension | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2375321 | solifenacin succinate 5 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375321 | solifenacin succinate 5 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375321 | solifenacin succinate 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375322 | solifenacin succinate 1 MG/ML [Vesicare] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2375323 | solifenacin Oral Suspension [Vesicare] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375324 | Vesicare Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2375325 | VESIcare LS 5 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375325 | VESIcare LS 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375325 | VESIcare LS 5 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375325 | VESIcare LS 5 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375326 | dupilumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2375327 | dupilumab 300 MG in 2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375327 | dupilumab 300 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375327 | dupilumab 300 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375328 | dupilumab Auto-Injector [Dupixent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375329 | DUPIXENT 300 MG in 2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375329 | DUPIXENT 300 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375329 | DUPIXENT 300 MG in 2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375329 | DUPIXENT 300 MG in 2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375330 | dupilumab 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375331 | dupilumab 150 MG/ML Auto-Injector [Dupixent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375331 | dupilumab 150 MG/ML Auto-Injector [Dupixent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375332 | minocycline 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2375333 | minocycline 1.5 % Topical Foam | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2375333 | minocycline 1.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375333 | minocycline 1.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375333 | minocycline 1.5 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375333 | minocycline 1.5 % Topical Foam | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2375334 | Zilxi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2375335 | minocycline 15 MG/ML [Zilxi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2375336 | minocycline Topical Foam [Zilxi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375337 | Zilxi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2375338 | ZILXI 1.5 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375338 | ZILXI 1.5 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375338 | ZILXI 1.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375338 | ZILXI 1.5 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237537 | invert sugar 50 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375518 | American eel preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375519 | betulonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2375520 | betulonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375521 | Cirsium japonicum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375522 | L-acetylleucine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375523 | Achillea ptarmica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375524 | Aconitum kusnezoffii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375525 | Gleditsia sinensis thorn extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375526 | Lactobacillus paracasei | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375526 | Lactobacillus paracasei | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375528 | Magnolia sprengeri whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375529 | Schisandra chinensis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375530 | symclosene sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2375531 | symclosene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375532 | alpha-asarone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375543 | trastuzumab-oysk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2375544 | trastuzumab-oysk 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2375546 | hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML [Herceptin Hylecta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2375703 | 1 daytime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2375703 | 1 daytime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375703 | 1 daytime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375703 | 1 daytime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375703 | 1 daytime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (4 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375705 | (2-hydroxyethyl)(hydroxymethyl)amine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375706 | 1-aminobutan-2-ol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375707 | Astragalus allochrous whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375708 | Caniquell | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2375709 | clomipramine hydrochloride 20 MG [Caniquell] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2375709 | clomipramine hydrochloride 20 MG [Caniquell] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375710 | clomipramine Oral Tablet [Caniquell] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375710 | clomipramine Oral Tablet [Caniquell] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375711 | Caniquell Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2375712 | Caniquell Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2375713 | CaniQuell 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375713 | CaniQuell 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375713 | CaniQuell 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375713 | CaniQuell 20 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375714 | clomipramine hydrochloride 40 MG [Caniquell] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2375714 | clomipramine hydrochloride 40 MG [Caniquell] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375715 | CaniQuell 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375715 | CaniQuell 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375715 | CaniQuell 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375715 | CaniQuell 40 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375716 | clomipramine hydrochloride 5 MG [Caniquell] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2375716 | clomipramine hydrochloride 5 MG [Caniquell] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375717 | CaniQuell 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375717 | CaniQuell 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375717 | CaniQuell 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375717 | CaniQuell 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375718 | clomipramine hydrochloride 80 MG [Caniquell] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2375718 | clomipramine hydrochloride 80 MG [Caniquell] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375719 | CaniQuell 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375719 | CaniQuell 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375719 | CaniQuell 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2375719 | CaniQuell 80 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2375720 | Galium boreale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375721 | Lycium chinense leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375722 | acid orange 20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375726 | isopropyl alcohol 0.005 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375727 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375727 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375727 | ethanol 70 % / isopropyl alcohol 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375728 | Pyelocalyceal Product | Dose Form Group (DFG) | Dose form group is a term type that serves as a grouping of dose forms related by route of administration or dose form. | YES |
| Concept ID (RxCUI): 2375729 | Powder for Pyelocalyceal Solution | Dose Form (DF) | YES | |
| Concept ID (RxCUI): 2375816 | mitomycin Pyelocalyceal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2375816 | mitomycin Pyelocalyceal Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375817 | mitomycin Powder for Pyelocalyceal Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2375817 | mitomycin Powder for Pyelocalyceal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375818 | mitoMYcin 40 MG Powder for Pyelocalyceal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375818 | mitoMYcin 40 MG Powder for Pyelocalyceal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2375818 | mitoMYcin 40 MG Powder for Pyelocalyceal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375818 | mitoMYcin 40 MG Powder for Pyelocalyceal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375818 | mitoMYcin 40 MG Powder for Pyelocalyceal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375819 | Jelmyto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2375820 | mitomycin 40 MG [Jelmyto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2375820 | mitomycin 40 MG [Jelmyto] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375821 | mitomycin Powder for Pyelocalyceal Solution [Jelmyto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375821 | mitomycin Powder for Pyelocalyceal Solution [Jelmyto] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375822 | Jelmyto Pyelocalyceal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2375823 | Jelmyto 40 MG Powder for Pyelocalyceal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375823 | Jelmyto 40 MG Powder for Pyelocalyceal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375823 | Jelmyto 40 MG Powder for Pyelocalyceal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375823 | Jelmyto 40 MG Powder for Pyelocalyceal Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2375823 | Jelmyto 40 MG Powder for Pyelocalyceal Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375828 | Cymbopogon flexuosus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2375829 | stepronin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2375838 | benzalkonium chloride 1.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2375839 | benzalkonium chloride 0.16 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2375839 | benzalkonium chloride 0.16 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2375839 | benzalkonium chloride 0.16 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375923 | ethylenediamine carbamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237593 | cysteine 325 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2375931 | 1 daytime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2375931 | 1 daytime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2375931 | 1 daytime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2375931 | 1 daytime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2375931 | 1 daytime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG per 10 mL Oral Solution) / 1 nighttime (6 OZ acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG per 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 237630 | corn oil 667 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237631 | dextrose 2.5 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237631 | dextrose 2.5 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237649 | dextrose 20 % in 500 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237649 | dextrose 20 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237649 | dextrose 20 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237649 | dextrose 20 % in 500 ML Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237649 | dextrose 20 % in 500 ML Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237650 | dextrose 40 % in 500 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237650 | dextrose 40 % in 500 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237650 | dextrose 40 % in 500 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237650 | dextrose 40 % in 500 ML Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237650 | dextrose 40 % in 500 ML Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237653 | dextrose 50 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237653 | dextrose 50 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237653 | dextrose 50 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237653 | dextrose 50 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237654 | dextrose 60 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237654 | dextrose 60 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237654 | dextrose 60 % Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237654 | dextrose 60 % Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237656 | dextrose 70 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237656 | dextrose 70 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237656 | dextrose 70 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2376830 | oleuropein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376838 | insulin lispro-aabc | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2376930 | ethanol, 2-(2-((4-((2-bromo-4,6-dinitrophenyl)azo)-1-naphthalenyl)amino)ethoxy)-, acetate (ester) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2376931 | Filipendula rubra whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2376933 | Lonicera dasystyla whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376934 | PEG-250 distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376935 | Pleiogynium timoriense fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376936 | polyglyceryl-3 pentaricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376938 | Yucca schidigera stem | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2376939 | carbobenzoxycarbonyl-phenylalanyl-alaninyldiazomethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376940 | Chamaecyparis obtusa wood extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2376941 | 2,4-dimethyl-3-cyclohexene carboxaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2376942 | ursodiol 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2376942 | ursodiol 400 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2376943 | formic acid, sodium salt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2376944 | (S)-amlodipine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237703 | hesperidin / vitamin C Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237703 | hesperidin / vitamin C Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377030 | Lactobacillus brevis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377030 | Lactobacillus brevis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2377031 | levamlodipine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237709 | vitamin C 1000 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237709 | vitamin C 1000 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237709 | vitamin C 1000 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377130 | Semglee | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2377131 | insulin glargine 100 UNT/ML [Semglee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2377132 | insulin glargine Injectable Solution [Semglee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377133 | Semglee Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2377134 | Semglee 100 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377134 | Semglee 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377134 | Semglee 100 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237715 | ascorbic acid 2000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237715 | ascorbic acid 2000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237715 | ascorbic acid 2000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237715 | ascorbic acid 2000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237716 | ascorbic acid 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237716 | ascorbic acid 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237716 | ascorbic acid 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237716 | ascorbic acid 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237717 | ascorbic acid 60 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237717 | ascorbic acid 60 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237717 | ascorbic acid 60 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237717 | ascorbic acid 60 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237718 | ascorbic acid 1500 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237718 | ascorbic acid 1500 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237718 | ascorbic acid 1500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237718 | ascorbic acid 1500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237719 | ascorbic acid 750 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237719 | ascorbic acid 750 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237719 | ascorbic acid 750 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237719 | ascorbic acid 750 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237720 | vitamin C 100 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237720 | vitamin C 100 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237720 | vitamin C 100 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237721 | vitamin C 250 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237721 | vitamin C 250 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237721 | vitamin C 250 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237722 | ascorbic acid 500 MG Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237722 | ascorbic acid 500 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237722 | ascorbic acid 500 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237722 | ascorbic acid 500 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237723 | ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377230 | insulin glargine Pen Injector [Semglee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377231 | Semglee 300 UNT in 3 mL Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377231 | Semglee 300 UNT in 3 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377231 | Semglee 300 UNT in 3 mL Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377231 | Semglee 300 UNT in 3 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377232 | insulin glargine 100 UNT/ML Pen Injector [Semglee] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2377232 | insulin glargine 100 UNT/ML Pen Injector [Semglee] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377233 | ethanol 69 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377233 | ethanol 69 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377233 | ethanol 69 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237726 | vitamin E 800 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237726 | vitamin E 800 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237730 | wheat germ oil 798 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237731 | wheat germ oil 1140 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237732 | wheat germ oil 171 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237733 | wheat germ oil 342 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237733 | wheat germ oil 342 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377332 | methotrexate Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2377333 | methotrexate 10 MG in 0.4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377333 | methotrexate 10 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377333 | methotrexate 10 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377334 | Reditrex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2377335 | methotrexate 25 MG/ML [Reditrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2377336 | methotrexate Prefilled Syringe [Reditrex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377337 | Reditrex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2377338 | RediTrex 10 MG in 0.4 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377338 | RediTrex 10 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377338 | RediTrex 10 MG in 0.4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377338 | RediTrex 10 MG in 0.4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377339 | methotrexate 25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377340 | methotrexate 25 MG/ML Prefilled Syringe [Reditrex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2377340 | methotrexate 25 MG/ML Prefilled Syringe [Reditrex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377341 | methotrexate 12.5 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377341 | methotrexate 12.5 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377341 | methotrexate 12.5 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377342 | RediTrex 12.5 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377342 | RediTrex 12.5 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377342 | RediTrex 12.5 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377342 | RediTrex 12.5 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377343 | methotrexate 15 MG in 0.6 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377343 | methotrexate 15 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377343 | methotrexate 15 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377344 | RediTrex 15 MG in 0.6 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377344 | RediTrex 15 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377344 | RediTrex 15 MG in 0.6 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377344 | RediTrex 15 MG in 0.6 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377345 | methotrexate 17.5 MG in 0.7 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377345 | methotrexate 17.5 MG in 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377345 | methotrexate 17.5 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377346 | RediTrex 17.5 MG in 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377346 | RediTrex 17.5 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377346 | RediTrex 17.5 MG in 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377346 | RediTrex 17.5 MG in 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377347 | methotrexate 20 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377347 | methotrexate 20 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377347 | methotrexate 20 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377348 | RediTrex 20 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377348 | RediTrex 20 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377348 | RediTrex 20 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377348 | RediTrex 20 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377349 | methotrexate 22.5 MG in 0.9 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377349 | methotrexate 22.5 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377349 | methotrexate 22.5 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377350 | RediTrex 22.5 MG in 0.9 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377350 | RediTrex 22.5 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377350 | RediTrex 22.5 MG in 0.9 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377350 | RediTrex 22.5 MG in 0.9 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377351 | methotrexate 25 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377351 | methotrexate 25 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377351 | methotrexate 25 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377352 | RediTrex 25 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377352 | RediTrex 25 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377352 | RediTrex 25 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377352 | RediTrex 25 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377353 | methotrexate 7.5 MG in 0.3 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377353 | methotrexate 7.5 MG in 0.3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377353 | methotrexate 7.5 MG in 0.3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377354 | RediTrex 7.5 MG in 0.3 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377354 | RediTrex 7.5 MG in 0.3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377354 | RediTrex 7.5 MG in 0.3 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377354 | RediTrex 7.5 MG in 0.3 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377355 | levamlodipine 1.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377356 | levamlodipine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2377356 | levamlodipine Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2377356 | levamlodipine Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2377357 | levamlodipine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2377358 | levamlodipine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2377359 | levamlodipine 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377359 | levamlodipine 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377359 | levamlodipine 1.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377360 | Conjupri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2377361 | levamlodipine 1.25 MG [Conjupri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2377362 | levamlodipine Oral Tablet [Conjupri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377363 | Conjupri Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2377364 | Conjupri Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2377365 | CONJUPRI 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377365 | CONJUPRI 1.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377365 | CONJUPRI 1.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377365 | CONJUPRI 1.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2377366 | levamlodipine 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2377367 | levamlodipine 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377367 | levamlodipine 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377367 | levamlodipine 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377368 | levamlodipine 2.5 MG [Conjupri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2377369 | CONJUPRI 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377369 | CONJUPRI 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377369 | CONJUPRI 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377369 | CONJUPRI 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 237737 | vitamin E 100 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237737 | vitamin E 100 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377370 | levamlodipine 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2377371 | levamlodipine 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2377371 | levamlodipine 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377371 | levamlodipine 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377371 | levamlodipine 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377371 | levamlodipine 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2377372 | levamlodipine 5 MG [Conjupri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2377373 | CONJUPRI 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377373 | CONJUPRI 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377373 | CONJUPRI 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377373 | CONJUPRI 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2377374 | resorcinol 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377375 | benzocaine 10 % / resorcinol 1.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377375 | benzocaine 10 % / resorcinol 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377375 | benzocaine 10 % / resorcinol 1.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377376 | ciclesonide 0.343 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377377 | ciclesonide 343 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377377 | ciclesonide 343 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377377 | ciclesonide 343 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377378 | Aservo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2377379 | ciclesonide 0.343 MG/ACTUAT [Aservo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 237738 | vitamin E 1000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377380 | ciclesonide Metered Dose Nasal Spray [Aservo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2377381 | Aservo Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2377382 | Aservo Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2377383 | Aservo EquiHaler 343 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377383 | Aservo EquiHaler 343 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377383 | Aservo EquiHaler 343 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377383 | Aservo EquiHaler 343 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2377384 | acetaminophen / dextromethorphan / guaifenesin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2377384 | acetaminophen / dextromethorphan / guaifenesin Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377385 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 237739 | vitamin E 180 MG (400 UNT) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237739 | vitamin E 180 MG (400 UNT) Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237739 | vitamin E 180 MG (400 UNT) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2377430 | ethanol 0.627 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377431 | ethanol 62.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377431 | ethanol 62.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377431 | ethanol 62.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377432 | benzalkonium chloride 1.35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377433 | benzalkonium chloride 0.135 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377433 | benzalkonium chloride 0.135 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377433 | benzalkonium chloride 0.135 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377434 | benzalkonium chloride 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2377435 | benzalkonium chloride 0.45 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377435 | benzalkonium chloride 0.45 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377435 | benzalkonium chloride 0.45 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2377530 | benzalkonium chloride 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2377530 | benzalkonium chloride 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2377530 | benzalkonium chloride 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237776 | cyanocobalamin 1000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237776 | cyanocobalamin 1000 MCG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237776 | cyanocobalamin 1000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237776 | cyanocobalamin 1000 MCG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237777 | cyanocobalamin 2000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237777 | cyanocobalamin 2000 MCG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237777 | cyanocobalamin 2000 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237777 | cyanocobalamin 2000 MCG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237778 | cyanocobalamin 500 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237778 | cyanocobalamin 500 MCG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237778 | cyanocobalamin 500 MCG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237778 | cyanocobalamin 500 MCG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237779 | vitamin B 12 1000 MCG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237779 | vitamin B 12 1000 MCG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237779 | vitamin B 12 1000 MCG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237779 | vitamin B 12 1000 MCG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237780 | cyanocobalamin 110 MG / intrinsic factor 0.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237780 | cyanocobalamin 110 MG / intrinsic factor 0.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237786 | folic acid 5 MG/ML injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237786 | folic acid 5 MG/ML injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237786 | folic acid 5 MG/ML injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237788 | leucovorin 350 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237788 | leucovorin 350 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237788 | leucovorin 350 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237788 | leucovorin 350 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237790 | vitamin B6 150 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237791 | vitamin B6 250 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237792 | vitamin B6 500 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237793 | riboflavin 100 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237794 | riboflavin 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237794 | riboflavin 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237794 | riboflavin 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237795 | riboflavin 250 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237797 | vit-B1 500 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237797 | vit-B1 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237797 | vit-B1 500 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2378 | Chlorbutol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2378 | Chlorbutol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2378 | Chlorbutol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2378 | Chlorbutol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2378 | Chlorbutol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2378 | Chlorbutol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2378030 | Boswellia frereana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2378230 | ethanol 0.06 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2378231 | benzalkonium / ethanol Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2378232 | benzalkonium / ethanol Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2378233 | benzalkonium chloride 0.1 % / ethanol 6 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2378233 | benzalkonium chloride 0.1 % / ethanol 6 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2378233 | benzalkonium chloride 0.1 % / ethanol 6 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237832 | sodium thiosulfate 12.5 GM in 50 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237832 | sodium thiosulfate 12.5 GM in 50 ML Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 237832 | sodium thiosulfate 12.5 GM in 50 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237832 | sodium thiosulfate 12.5 GM in 50 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237832 | sodium thiosulfate 12.5 GM in 50 ML Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 237834 | activated charcoal / simethicone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237836 | activated charcoal 260 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237836 | activated charcoal 260 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237837 | activated charcoal 325 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237846 | sodium fluoride 5 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237847 | stannous fluoride 0.4 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237847 | stannous fluoride 0.4 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237847 | stannous fluoride 0.4 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237865 | calcium carbonate 400 MG / magnesium hydroxide 135 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237865 | calcium carbonate 400 MG / magnesium hydroxide 135 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237865 | calcium carbonate 400 MG / magnesium hydroxide 135 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237867 | calcium carbonate 420 MG (Ca 168) / simethicone 21 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237867 | calcium carbonate 420 MG (Ca 168) / simethicone 21 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237870 | aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237871 | aluminum hydroxide 180 MG / milk of magnesia 160 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237871 | aluminum hydroxide 180 MG / milk of magnesia 160 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237872 | aluminum hydroxide 200 MG / magnesium hydroxide 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237872 | aluminum hydroxide 200 MG / magnesium hydroxide 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237872 | aluminum hydroxide 200 MG / magnesium hydroxide 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237873 | aluminum hydroxide 248 MG / milk of magnesia 75 MG Chewable Tab | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237873 | aluminum hydroxide 248 MG / milk of magnesia 75 MG Chewable Tab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237878 | aluminum hydroxide 450 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237878 | aluminum hydroxide 450 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2378832 | 10-undecenal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378833 | 1H,5H-cyclopenta(3,4)(1)benzopyrano(6,7,8-IJ)quinolizin-12(9H)-one, 2,3,6,7,10,11-hexahydro- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378834 | 2,6,10-trimethyl-9-undecenal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378835 | 2-acetonaphthone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2378836 | 2-methylundecanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378838 | Lobelia purpurescens extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2378838 | Lobelia purpurescens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378839 | Cosmos sulphureus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2378840 | cuminyl acetaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2378841 | dexamethasone acetate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2378842 | alpha-tocopherol, L- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 237885 | Pepsin powder | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 237885 | Pepsin powder | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237890 | lactase 230 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237890 | lactase 230 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237892 | lactase 3000 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237892 | lactase 3000 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237896 | simethicone 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237896 | simethicone 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237899 | attapulgite / pectin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 23790 | Lymphocyte antigen CD99 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23790 | Lymphocyte antigen CD99 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 237900 | attapulgite 750 MG / pectin 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237900 | attapulgite 750 MG / pectin 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2379030 | sodium monofluorophosphate 0.0038 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2379031 | sodium monofluorophosphate 0.38 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2379031 | sodium monofluorophosphate 0.38 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2379031 | sodium monofluorophosphate 0.38 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237913 | paregoric Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237915 | cascara sagrada / phenolphthalein Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237927 | sennosides, USP 12 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237928 | sennosides 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237928 | sennosides 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237931 | sennosides, USP 65 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237940 | phenolphthalein 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237940 | phenolphthalein 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237941 | phenolphthalein 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237941 | phenolphthalein 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237942 | phenolphthalein 90 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 237942 | phenolphthalein 90 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237951 | mineral oil Enema | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2379530 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2379531 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 237954 | magnesium sulfate 266.7 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237955 | magnesium citrate 4000 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 23796 | ebastine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2379630 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2379631 | influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2379632 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2379633 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2379633 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2379633 | influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2379634 | Fluarix Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2379635 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2379636 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2379637 | Fluarix Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2379638 | FLUARIX QUADRIVALENT 2020-2021 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2379638 | FLUARIX QUADRIVALENT 2020-2021 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2379638 | FLUARIX QUADRIVALENT 2020-2021 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2379639 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2379640 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 237969 | Plantago seed 806 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2379731 | mcpa triisopropanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2379732 | Flulaval Quadrivalent 2020-2021 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2379733 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2020-2021] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2379734 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2020-2021] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2379735 | Flulaval Quadrivalent 2020-2021 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2379736 | FLULAVAL QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2379736 | FLULAVAL QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2379736 | FLULAVAL QUADRIVALENT 2020-2021 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2379737 | influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2020-2021] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 237976 | fiber Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 237977 | potassium bitartrate / sodium bicarbonate Rectal Suppository | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 237982 | sincalide 5 MCG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 237982 | sincalide 5 MCG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 237982 | sincalide 5 MCG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 237998 | amylases 30,000 UNT / endopeptidases 30,000 UNT / lipase 11,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 237998 | amylases 30,000 UNT / endopeptidases 30,000 UNT / lipase 11,000 UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 237998 | amylases 30,000 UNT / endopeptidases 30,000 UNT / lipase 11,000 UNT Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |